Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Keisu

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
European Journal of Clinical Pharmacology|January 1, 1992
Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidenceM Keisu, E Ekman
European Journal of Haematology|July 1, 1990
Diagnoses in patients with severe pancytopenia suspected of having aplastic anemiaM Keisu, A Ost
Handbook of Experimental Pharmacology|December 19, 2009
Drug-induced liver injury in humans: the case of ximelagatranM Keisu, T B Andersson
Scandinavian Journal of Infectious Diseases|January 1, 1991
How safe is proguanil? A post-marketing investigation of side-effectsB Eriksson, A Björkman, M Keisu
Lakartidningen|July 23, 1997
[The decisive steps cost billions. Extensive studies provide answers for many questions]A Wallström, A Rosén, M Keisu
European Journal of Clinical Pharmacology|January 1, 1992
Comparing risk estimates of sulphonamide-induced agranulocytosis from the Swedish Drug Monitoring System and a case-control studyM Keisu, E Ekman, B E Wiholm
Journal of Internal Medicine|October 1, 1990
Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting systemM Keisu, B E Wiholm, J Palmblad
Lakartidningen|January 21, 1987
[Neutropenia--causes, mechanism and therapy]J Palmblad, M Keisu, J E Olsson
Archives of Dermatology|July 1, 1990
The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988P Hörnsten, M Keisu, B E Wiholm
Drug Safety|January 1, 1990
Could Swedish 'yellow cards' be substituted by E-coded summaries?C Jorup-Rönström, M Keisu, B E Wiholm
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
European Journal of Clinical Pharmacology|January 1, 1992
Sulfasalazine associated agranulocytosis in Sweden 1972-1989. Clinical features, and estimation of its incidenceM Keisu, E Ekman
European Journal of Haematology|July 1, 1990
Diagnoses in patients with severe pancytopenia suspected of having aplastic anemiaM Keisu, A Ost
Handbook of Experimental Pharmacology|December 19, 2009
Drug-induced liver injury in humans: the case of ximelagatranM Keisu, T B Andersson
Scandinavian Journal of Infectious Diseases|January 1, 1991
How safe is proguanil? A post-marketing investigation of side-effectsB Eriksson, A Björkman, M Keisu
Lakartidningen|July 23, 1997
[The decisive steps cost billions. Extensive studies provide answers for many questions]A Wallström, A Rosén, M Keisu
European Journal of Clinical Pharmacology|January 1, 1992
Comparing risk estimates of sulphonamide-induced agranulocytosis from the Swedish Drug Monitoring System and a case-control studyM Keisu, E Ekman, B E Wiholm
Journal of Internal Medicine|October 1, 1990
Trimethoprim-sulphamethoxazole-associated blood dyscrasias. Ten years' experience of the Swedish spontaneous reporting systemM Keisu, B E Wiholm, J Palmblad
Lakartidningen|January 21, 1987
[Neutropenia--causes, mechanism and therapy]J Palmblad, M Keisu, J E Olsson
Archives of Dermatology|July 1, 1990
The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988P Hörnsten, M Keisu, B E Wiholm
Drug Safety|January 1, 1990
Could Swedish 'yellow cards' be substituted by E-coded summaries?C Jorup-Rönström, M Keisu, B E Wiholm
Pageof 2